Abstract Library

Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.

Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.

ENETS Abstract Search

#2032 Current Educational Strategies Used by Nurses Caring for NET Patients: Electronic Survey across 25 Countries

Introduction: The ENETS Nurse Group performed a short pilot survey in 2015 to locate nurses who take care of NET patients and to explore NET nurse education needs. The results of this survey were used to design a more detailed electronic survey.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Davies P

Authors: Davies P, Falkerby J, Geilvoet W, Fernandez Ortega M, Munk Plum L,

Keywords: Nurse, Education, Neuroendocrine Tumor,

#1799 Pilot Electronic Survey to Locate Nurses Caring for NET Patients in Europe.

Introduction: There is an assumed variance in the roles nurses have in looking after NET patients, and the different levels of knowledge.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Davies P

Authors: Davies P, Falkerby J, Geilvoet W, Fernandez Ortega M, Mordel K,

Keywords: nurse, neuroendocrine, education, survey,

#503 Long-Term Stable Disease with Everolimus in a Patient with Advanced Pancreatic Neuroendocrine Tumor Enrolled in RADIANT-1

Introduction: The phase II open-label RADIANT-1 study evaluated the safety and efficacy of Everolimus (E, 10 mg/d) ± octreotide LAR (O) in patients (pts) with advanced pancreatic neuroendocrine tumors (pNET) after chemotherapy failure. Objective tumor response was 9.6% in the E group and 4.4% in the E+O group (all partial), and stable disease (SD) was 68% and 80%.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Falkerby J, Granberg D, Eriksson B, Skogseid B, Öberg K,

Keywords: neuroendocrine, Everolimus, pancreatic,